Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- A. Keith Stewart, MD
Mayo Clinic
Study Chair - Martha Q. Lacy, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Center
Halifax, Nova Scotia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Odette Cancer Centre
Toronto, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University - Dept. Oncology
Montreal, Quebec, Canada
- Cha-Hopital Du St-Sacrement
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Oct 2002
- Primary completion
- 19 Oct 2011
- Completion
- 19 Sept 2013
- Last update posted
- 13 Sept 2023
- Registered enrollment
- 332
- Registry id
- NCT00049673
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.